NasdaqHealth CarePharmaceutical PreparationsSCOTTSDALE, AZ

Journey Medical Corporation DERM

Ask your AI

Estimated market cap $122.24M28.23M shares, shares as of Nov 12, 2026CIK 1867066

Insider trades, 12 mo

—

No open-market trades

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q3 2026

17.9% of shares · 11 added

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

Latest 10-Q

Q3 2026

What changed in Journey Medical Corporation's latest quarterly report, compared with the one before.

Filed Nov 12, 2026 · Quarter ended Sep 30, 2026

Compared with the 10-Q for the quarter ended Jun 30, 2026. Sections compared: management's discussion, risk factors, legal proceedings and controls and procedures.

Read the 10-Q on sec.gov ↗Filing index ↗

Latest 10-Q

What changed in Journey Medical Corporation's latest quarterly report, compared with the one before.

Loading…

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

No open-market insider trades reported since May 2, 2025. Insiders have two business days to file.

Recent insider trades

Claude Maraoui President & CEO, Director	May 2, 2025 Form 4 ↗	Sale	−$33.1K 4,834 sh @ $6.84	-71.5%
Joseph Benesch CFO	May 2, 2025 Form 4 ↗	Sale	−$16.5K 2,409 sh @ $6.84	-71.5%
Ramsey Alloush COO	May 2, 2025 Form 4 ↗	Sale	−$19.5K 2,857 sh @ $6.84	-71.5%
Claude Maraoui President & CEO, Director	Mar 11, 2025 Form 4 ↗	Sale	−$246.8K 49,271 sh @ $5.01	-51.6%
Claude Maraoui President & CEO, Director	Mar 7, 2025 Form 4 ↗	Sale	−$74.7K 14,905 sh @ $5.01	-46.7%

All DERM insider trades →Planned sales (Form 144): see notices

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

3.97M shares

44 funds report DERM. Values checked against market prices.

Q3 2026. 9 new, 11 added to, 15 trimmed, 37 exited since Q2 2026.

Top 13F holders
#
1	Vanguard Capital Management LLC 13F ↗	675,185	$4.6M	unchanged
2	Pale Fire Capital SE 13F ↗	521,841	$3.6M	-1.3%
3	First Eagle Investment Management, LLC 13F ↗	483,207	$3.3M	New
4	Summit Financial, LLC 13F ↗	344,214	$2.4M	-0.7%
5	Renaissance Technologies LLC 13F ↗	228,900	$1.6M	-0.3%
6	Geode Capital Management, LLC 13F ↗	202,066	$1.4M	-6.5%
7	Marshall Wace, LLP 13F ↗	194,311	$1.3M	+38.9%
8	American Financial Group Inc 13F ↗	180,000	$1.2M	unchanged
9	UBS Group AG 13F ↗	160,066	$1.1M	+91.7%
10	Morgan Stanley 13F ↗	122,073	$835.0K	+190.5%

Download CSV Every fund that holds DERM, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What Journey Medical Corporation and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What Journey Medical Corporation and its lobbying firms report each quarter.

Loading…

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report

Funds holding the stock by quarter

Q4 2021	14	—	1.63M	$8.8M
Q1 2022	14	0	1.64M	$7.9M
Q2 2022	12	-2	1.74M	$6.5M
Q3 2022	20	+8	1.88M	$4.6M
Q4 2022	18	-2	2.67M	$5.1M
Q1 2023	17	-1	1.69M	$51.4M
Q2 2023	20	+3	1.65M	$2.6M
Q3 2023	21	+1	2.14M	$5.9M
Q4 2023	36	+15	1.36M	$8.1M
Q1 2024	33	-3	1.82M	$6.7M
Q2 2024	35	+2	2.36M	$13.3M
Q3 2024	36	+1	2.16M	$12.2M
Q4 2024	37	+1	3.79M	$14.8M
Q1 2025	38	+1	5.08M	$30.0M
Q2 2025	56	+18	6.50M	$46.6M
Q3 2025	68	+12	8.70M	$62.0M
Q4 2025	77	+9	11.02M	$85.0M
Q1 2026	72	-5	11.87M	$55.8M
Q2 2026	71	-1	10.66M	$75.5M
Q3 2026	44	-27	3.97M	$27.2M

Each point is a quarter-end, from Q4 2021 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (48115J109). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q4 2021) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits; none took place between these quarters. Values are in dollars as reported at the time and are not adjusted.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakes5 in 12 mo 8-K events1 in 90 days Patents4 patents granted Short interestFINRA · updated Oct 15 Planned insider salesNone in 12 mo Executive payNone on record Wikipedia attentionNone on record SEC enforcementNone on record Clinical trials0 active IPO history1 registration Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: Journey Medical Corp
Address: 9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE, AZ 85258
Phone: 480-434-6670
Fiscal year ends: Dec 31
Filer category: Non-accelerated filer, smaller reporting company, emerging growth company
Incorporated in: DE
Listed as: DERM (Nasdaq)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$4.33−$0.06 (−1.37%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $4.30 · High $5.68Nov 13, 2026

Aug 13, 2026Low $4.30 · High $7.97Nov 13, 2026

Nov 13, 2025Low $4.30 · High $9.26Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.